» Articles » PMID: 3147473

The Chlordiazepoxide/pentylenetetrazol Discrimination: Characterization of Drug Interactions and Homeostatic Responses to Drug Challenges

Overview
Specialty Pharmacology
Date 1988 Jan 1
PMID 3147473
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Rats were trained to discriminate chlordiazepoxide (CDP) from pentylenetetrazol (PTZ) in a two-lever food motivated discrimination task. Training drug doses were adjusted until subjects emitted approximately 50% of their responses on each of the two drug-appropriate levers during saline injection tests. Tests that followed injection of CDP/PTZ combinations illustrated a reciprocal antagonism between the two drugs. Saline-injection tests that followed large dose injections of CDP revealed a period of predominantly PTZ-appropriate responding that persisted after the initial period of predominantly CDP-appropriate responding. These data are interpreted to suggest that, unlike some other drugs that have been shown to antagonize the behavioral and CNS effects of benzodiazepines, the interoceptive stimulus generated by PTZ occupies a position opposite to that of CDP along some single affective continuum. In addition, these data suggest that drug/drug (DD) discriminations are capable of characterizing the interactions between training drugs. Finally, the data suggest that the CDP/PTZ discrimination is a sensitive detector of bidirectional shifts in interoceptive stimulus state along the CDP/PTZ continuum.

Citing Articles

Drug discrimination is a continuous rather than a quantal process following training on a VI-TO schedule of reinforcement.

Barrett R, CAUL W, Huffman E, Smith R Psychopharmacology (Berl). 1994; 113(3-4):289-96; discussion 297-303.

PMID: 7862836 DOI: 10.1007/BF02245196.


Time dependent pentylenetetrazol-like cues subsequent to diazepam administration.

Barrett R, Smith R Psychopharmacology (Berl). 1988; 96(2):169-73.

PMID: 3148142 DOI: 10.1007/BF00177556.


Increased drug sensitivity in the drug discrimination procedure afforded by drug versus drug training.

Boja J, SCHECHTER M Psychopharmacology (Berl). 1990; 102(2):221-6.

PMID: 2274604 DOI: 10.1007/BF02245925.


Animal models of drug withdrawal symptoms.

Mathis D, Moon R, Lal H Psychopharmacology (Berl). 1990; 101(3):292-309.

PMID: 1972994 DOI: 10.1007/BF02244046.


Tolerance, withdrawal, and supersensitivity to dopamine mediated cues in a drug-drug discrimination.

Barrett R, White D, CAUL W Psychopharmacology (Berl). 1992; 109(1-2):63-7.

PMID: 1365673 DOI: 10.1007/BF02245481.

References
1.
Tallman J, Paul S, Skolnick P, Gallager D . Receptors for the age of anxiety: pharmacology of the benzodiazepines. Science. 1980; 207(4428):274-81. DOI: 10.1126/science.6101294. View

2.
Petursson H, Lader M . Withdrawal from long-term benzodiazepine treatment. Br Med J (Clin Res Ed). 1981; 283(6292):643-5. PMC: 1506756. DOI: 10.1136/bmj.283.6292.643. View

3.
White F, Appel J . Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological actions. Science. 1982; 216(4545):535-7. DOI: 10.1126/science.7071600. View

4.
Lal H . Behavioral analogues of anxiety. Animal models. Neuropharmacology. 1983; 22(12B):1423-41. DOI: 10.1016/0028-3908(83)90111-9. View

5.
Phillis JW Siemens R, Siemens R, Wu P . Effects of diazepam on adenosine and acetylcholine release from rat cerebral cortex: further evidence for a purinergic mechanism in action of diazepam. Br J Pharmacol. 1980; 70(2):341-8. PMC: 2044332. DOI: 10.1111/j.1476-5381.1980.tb07942.x. View